The Patient-Reported Outcomes Project of HCV-TARGET (PROP-UP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02601820|
Recruitment Status : Completed
First Posted : November 10, 2015
Results First Posted : September 16, 2019
Last Update Posted : September 16, 2019
|Study Design||Observational Model: Cohort; Time Perspective: Prospective|
Hepatitis C, Chronic
11 liver or gastroenterology centers in the United States: 9 academic medical centers, 2 private gastroenterology centers.
1601 patients officially enrolled who provided informed consent, completed baseline patient-reported outcome (PRO) surveys and were prescribed one of five direct acting antiviral treatment regimens for chronic hepatitis C.
|Pre-assignment Details||None. Observational study included enrolled patients who completed PRO data at follow-up time periods.|